Frank Antonicelli Selected Research

valyl-glycyl-valyl-alanyl-prolyl-glycine

1/2021	The elastin peptide VGVAPG increases CD4+ T-cell IL-4 production in patients with chronic obstructive pulmonary disease.
5/2013	Impairment of neutrophil reactivity to elastin peptides in COPD.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Frank Antonicelli Research Topics

Disease

15	Bullous Pemphigoid (Pemphigoid) 01/2019 - 03/2011
15	Neoplasms (Cancer) 12/2018 - 02/2004
8	Blister (Bulla) 01/2019 - 01/2014
6	Melanoma (Melanoma, Malignant) 01/2016 - 02/2004
5	Inflammation (Inflammations) 01/2019 - 06/2004
3	Breast Neoplasms (Breast Cancer) 12/2018 - 01/2015
3	Pemphigus (Pemphigus Vulgaris) 01/2018 - 05/2013
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2021 - 05/2013
2	Autoimmune Diseases (Autoimmune Disease) 01/2018 - 03/2017
2	Neoplasm Metastasis (Metastasis) 02/2017 - 08/2016
2	Carcinogenesis 08/2016 - 07/2015
2	Fibrosarcoma 01/2015 - 06/2011
2	Thyroid Neoplasms (Thyroid Cancer) 05/2007 - 05/2007
2	Lung Diseases (Lung Disease) 06/2004 - 03/2002
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2019
1	Hidradenitis Suppurativa 01/2019
1	Systemic Scleroderma (Systemic Sclerosis) 01/2018
1	Epidermolysis Bullosa Acquisita (Acquired Epidermolysis Bullosa) 01/2018
1	Connective Tissue Diseases (Connective Tissue Disease) 01/2018
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2018
1	Rheumatoid Arthritis 01/2018
1	Myositis (Idiopathic Inflammatory Myopathies) 01/2018
1	Urticaria (Hives) 01/2018
1	Vesiculobullous Skin Diseases (Subcorneal Pustular Dermatosis) 01/2018
1	Erythema 01/2018
1	Parkinson Disease (Parkinson's Disease) 08/2017
1	Dementia (Dementias) 08/2017
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 08/2017
1	Hematologic Neoplasms (Hematological Malignancy) 02/2017
1	Multiple Myeloma 02/2017
1	Glucocorticoid Receptor Deficiency 02/2017
1	Triple Negative Breast Neoplasms 08/2016
1	Choristoma (Ectopic Tissue) 01/2015
1	Skin Diseases (Skin Disease) 12/2014

Drug/Important Bio-Agent (IBA)

11	Interleukin-17 (Interleukin 17)IBA 01/2021 - 12/2014
11	CytokinesIBA 01/2021 - 03/2002
9	AutoantibodiesIBA 01/2018 - 05/2013
6	Peptides (Polypeptides)IBA 01/2021 - 02/2004
6	Matrix Metalloproteinases (MMPs)IBA 01/2019 - 01/2007
6	Proteins (Proteins, Gene)FDA Link 12/2017 - 06/2003
5	Peptide Hydrolases (Proteases)FDA Link 01/2021 - 12/2014
5	cyclohexenoesculetin-beta-galactoside (S-Gal)IBA 01/2021 - 02/2004
5	ElastinIBA 01/2021 - 02/2004
4	Interleukin-23 (Interleukin 23)IBA 01/2019 - 12/2014
3	EnzymesIBA 05/2013 - 05/2007
3	Collagen Type I (Type I Collagen)IBA 07/2005 - 02/2004
2	valyl-glycyl-valyl-alanyl-prolyl-glycineIBA 01/2021 - 05/2013
2	AntibodiesIBA 01/2019 - 01/2018
2	Interleukin-22 (IL-22)IBA 01/2019 - 12/2014
2	Biological ProductsIBA 01/2019 - 01/2007
2	Biomarkers (Surrogate Marker)IBA 12/2017 - 03/2017
2	Matrix Metalloproteinase 9 (Gelatinase B)IBA 03/2017 - 05/2007
2	Decitabine FDA Link 01/2015 - 06/2011
2	Transforming Growth Factors (Transforming Growth Factor)IBA 12/2014 - 06/2003
2	ImmunosorbentsIBA 05/2013 - 03/2011
2	Histone Deacetylase InhibitorsIBA 06/2011 - 10/2008
2	trichostatin A (A 300)IBA 06/2011 - 10/2008
2	elastin-binding proteinsIBA 09/2009 - 02/2004
2	Transcription Factors (Transcription Factor)IBA 05/2007 - 03/2003
2	Matrix Metalloproteinase 14 (MT1-MMP)IBA 01/2007 - 02/2004
2	NF-kappa B (NF-kB)IBA 03/2003 - 01/2003
1	DesmosineIBA 01/2021
1	Interleukin-4 (Interleukin 4)IBA 01/2021
1	InflammasomesIBA 01/2019
1	Interleukin-17 ReceptorsIBA 01/2019
1	Protein Isoforms (Isoforms)IBA 01/2019
1	InterleukinsIBA 01/2019
1	beta-cyclodextrin tetradecasulfate (CTDS)IBA 01/2018
1	Collagen Type VIIIBA 01/2018
1	Rituximab (Mabthera)FDA Link 01/2018
1	glucocorticoid receptor betaIBA 12/2017
1	Spironolactone (Aldactone)FDA LinkGeneric 08/2017
1	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 08/2017
1	Antipsychotic Agents (Antipsychotics)IBA 08/2017
1	Chemokine CXCL10IBA 03/2017
1	GlucocorticoidsIBA 02/2017
1	Leukotriene B4IBA 01/2017
1	Chimeric Antigen ReceptorsIBA 01/2017
1	Doxycycline (Periostat)FDA LinkGeneric 01/2017
1	Dapsone FDA Link 01/2017
1	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 01/2017
1	Eosinophil Cationic ProteinIBA 01/2017
1	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2017
1	Dimethyl FumarateIBA 01/2017
1	ErbB Receptors (EGF Receptor)IBA 08/2016
1	Estrogen ReceptorsIBA 08/2016
1	Progesterone Receptors (Progesterone Receptor)IBA 08/2016
1	Propolis (Bee Bread)IBA 01/2016
1	galanginIBA 01/2016
1	FlavonoidsIBA 01/2016
1	Cyclin EIBA 07/2015
1	Messenger RNA (mRNA)IBA 07/2015
1	70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA 07/2015
1	Ribosomal Protein S6 Kinases (S6 Kinase)IBA 07/2015
1	DNA (Deoxyribonucleic Acid)IBA 01/2015
1	Phenobarbital (Luminal)FDA Link 01/2015
1	Pharmaceutical PreparationsIBA 01/2015
1	Interleukin-6 (Interleukin 6)IBA 12/2014

Therapy/Procedure

3	Therapeutics 01/2019 - 01/2016
1	Drug Therapy (Chemotherapy) 08/2016